http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20190478-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35569a89252e84b39aa7d239be97789c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
filingDate 2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3856607eff631ba6fb3374863619a67b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a62e1623372abf6b7f5787b60e40373d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23922ff1cfaf79809f3c0b36792d7be3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7c19504fb2c5d0f284058540b623661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe416a832929e311458abbd8df20733
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6350476b07d8a3d9c2b3e12c18eb13
publicationDate 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20190478-A1
titleOfInvention IMIDAZOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY OR AUTOIMMUNE OR CANCER DISEASES
abstract It refers to derivatives of imidazole, a compound of formula I or a salt thereof in which R2 is hydrogen, C1-C6 alkyl, C1-C6 alkoxy, C3-C7 cycloalkyl, among others; R3 can be halogen, -CN, C1-3 alkyl, C1-3 alkoxy, -NO2, among others; a represents 0, 1 or 2. Preferred compounds are 5- (1 H -imidazol-2-yl) -1,3-dimethylpyridin-2 (1 H) -one; 5- (4-Bromo-1-ethyl-1h-imidazol-2-yl) -1,3-dimethylpyridin-2 (1H) -one; 1,3-dimethyl-5- (1 - ((tetrahydro-2H-pyran-4-yl) methyl) -1H-imidazol-2-yl) pyridin-2 (1H) -one. Said compound modulates the binding to proteins that contain bromodomins such as, for example, acetylated lysine residues and are useful in the treatment of diseases such as rheumatoid arthritis and cancer.
priorityDate 2016-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430291852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134306034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134308372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429665153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134306038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429665113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795

Total number of triples: 41.